The global market for biotechnology is expected to reach USD 604.40 billion by 2020. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next six years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.

View Full Report with TOC @ http://www.radiantinsights.com/research/biotechnology-market-biopharmacy-bioservices-bioagriculture-bioindustrial-fermentation-dna-sequencing-tissue-engineering-regeneration-analysis-and-segment-forecasts-to-2020

Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopharmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology.

Further key findings from the study suggest:

North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.
Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.
Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.
Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy's Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.
For the purpose of this study, report has segmented the global biotechnology market on the basis of application and region:
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/biotechnology-market-biopharmacy-bioservices-bioagriculture-bioindustrial-fermentation-dna-sequencing-tissue-engineering-regeneration-analysis-and-segment-forecasts-to-2020/request-sample

Biotechnology Application Outloot

Medical Gases
BioPharmacy
BioServices
BioAgriculture
BioIndustrial
Biotechnology Technology Outlook

Fermentation
Tissue engineering and Regeneration
PCR Tehnology
Nanobiotechnology
Chromatography Market
DNA Sequencing
Cell Based Assay
Biotechnology Regional Outlook

North America
Europe
Asia Pacific
RoW
Browse Other Reports of This Category at: http://www.radiantinsights.com/catalog/biotechnology

About Radiant Insights,Inc

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: [email protected]

Web: http://www.radiantinsights.com/